Summary of Significant Accounting Policies (Tables)

9 Months Ended

Sep. 30, 2020

Summary of Significant Accounting Policies

Schedule of disaggregation of revenue by major source

The following table disaggregates our revenues by major source for the three and nine months ended September 30, 2020 and 2019:

	Three Months Ended September 30,				Nine Months Ended September 30,
(000’s omitted)	2020		2019		2020		2019
Global Logistics Solutions:
Biopharmaceutical	$	8,413	$	7,460	$	23,214	$	20,059
Reproductive medicine		1,189		735		2,551		2,191
Animal health		223		219		664		705
Total Global Logistics Solutions		9,825		8,414		26,429		22,955
Global Bioservices		1,347		1,169		3,906		1,745
Total revenues	$	11,172	$	9,583	$	30,335	$	24,700

Schedule of geographical revenues, by origin

Our geographical revenues, by origin, for the three and nine months ended September 30, 2020 and 2019, were as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
(000’s omitted)	2020		2019		2020		2019
Americas	$	8,750	$	7,708	$	23,837	$	21,413
Europe, the Middle East and Africa (EMEA)		2,009		1,699		5,704		2,786
Asia Pacific (APAC)		413		176		794		501
Total revenues	$	11,172	$	9,583	$	30,335	$	24,700

Schedule of net loss per share

The following shows the amounts used in computing net loss per share for the three and nine months ended September 30, 2020 and 2019:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2020		2019		2020		2019
Net loss	$	(11,417,821)	$	(12,468,547)	$	(21,163,460)	$	(17,383,940)
Weighted average common shares issued and outstanding – basic and diluted		39,144,916		35,674,162		38,211,327		32,449,940
Basic and diluted net loss per share	$	(0.29)	$	(0.35)	$	(0.55)	$	(0.54)

Schedule of number of shares excluded from the computation of diluted loss per share

The following table sets forth the number of shares excluded from the computation of diluted loss per share, as their inclusion would have been anti-dilutive:

	Three Months Ended September 30,		Nine Months Ended September 30,
	2020	2019	2020	2019
Stock options	5,823,629	4,437,527	4,932,353	3,821,040
Warrants	—	917,757	—	857,111
Convertible senior notes	4,810,002	1,158,183	4,810,002	1,158,183
	10,633,631	6,513,467	9,742,355	5,836,334